Cellectis (CLLS) Notes Payables (2014 - 2016)

Cellectis (CLLS) recorded quarterly Notes Payables of $2.1 million in Q1 2016, down 0.68% quarter-over-quarter from $2.1 million in Q4 2015.

Cellectis (CLLS) Notes Payables (2014 - 2016) Analysis & Trends

Cellectis' Notes Payables history runs 3 years deep, the most recent figure standing at $2.1 million for Q1 2016.

  • In Q1 2016, Notes Payables changed N/A year-over-year to $2.1 million; the TTM figure through Mar 2016 stood at $2.1 million (changed N/A YoY), while the FY2015 annual figure was $2.1 million, up 98.06% from the prior year.
  • Notes Payables was $2.1 million for Q1 2016 at Cellectis, down from $2.1 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $3.4 million in Q2 2015 to a low of $1.1 million in Q4 2014.
  • Historically, Notes Payables has averaged $2.4 million across 3 years, with a median of $2.1 million in 2015.
  • Biggest YoY gain for Notes Payables was 95.45% in 2015; the steepest drop was 95.45% in 2015.
  • A 3-year view of Notes Payables shows it stood at $1.1 million in 2014, then jumped by 95.45% to $2.1 million in 2015, then slipped by 0.68% to $2.1 million in 2016.
  • The last three Notes Payables figures came in at $2.1 million (Q1 2016), $2.1 million (Q4 2015), and $3.3 million (Q3 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Cellectis 17.40 Bn 17.21 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2016 2.09 Mn
Dec 31, 2015 2.11 Mn
Sep 30, 2015 3.32 Mn
Jun 30, 2015 3.35 Mn
Dec 31, 2014 1.08 Mn